Acadia Healthcare, a prominent leader in the behavioral health sector, recently announced the appointment of Dr. Nasser Khan as its new Chief Operating Officer. This significant move, which was reported by BHBusiness, marks the first time the company has integrated a COO role into its executive suite, reflecting its commitment to expanding and enhancing its operations. Dr. Khan will assume his duties on June 30, succeeding John Hollinsworth, who is set to retire but will remain in an advisory capacity through the end of 2024 to ensure a smooth transition.
Dr. Nasser Khan brings a wealth of experience to Acadia Healthcare, having previously served as the Operations Group President for the company’s Comprehensive Treatment Center (CTC) business line. As reported by Acadia Healthcare’s Official Website, his track record encompasses a robust background in healthcare management, including a senior vice president position at Shields Health Solutions, a subsidiary of Walgreens Boots Alliance. With a medical degree and a history of leadership roles at notable healthcare organizations like DaVita and Biograph, Dr. Khan is poised to drive Acadia’s mission of providing high-quality care to patients struggling with behavioral health issues.
In a recent interview, Dr. Khan articulated his priorities for his new role, emphasizing a focus on service to both patients and staff, alongside a commitment to improving quality and clinical outcomes. This emphasis on people reflects Acadia’s holistic approach to behavioral health, where both patient care and employee welfare are seen as interdependent.
Acadia Healthcare has been on an ambitious growth trajectory, particularly within its CTC division. According to Crunchbase, the company plans to open 14 new CTCs in 2024 and recently acquired several facilities in North Carolina. This expansion is part of a broader five-point growth strategy that includes facility expansion, new facility development, joint ventures, strategic acquisitions, and enhancing the care continuum. Dr. Khan’s leadership is expected to play a pivotal role in executing this strategy, which aligns with the pressing need for comprehensive addiction treatment services, especially in the context of the ongoing opioid epidemic.
Despite facing a dip in patient volumes in the first quarter of 2024, Acadia Healthcare remains optimistic about meeting its year-end projections. This strategic thinking is indicative of Dr. Khan’s background in healthcare consulting, which equips him to navigate the complexities of the behavioral health landscape.
Additionally, Acadia is keen on expanding its outpatient services, including partial hospitalization and intensive outpatient programs, which have been identified as having significant growth potential. This focus on diversifying service offerings is critical, as it allows Acadia to adapt to the changing needs of the populations it serves.
Dr. Nasser Khan’s appointment as COO of Acadia Healthcare signals a transformative phase for the organization. As the company moves forward, it will undoubtedly continue to reflect on its core values, ensuring that high-quality care remains at the forefront of its mission.